1. Home
  2. DSY vs CTOR Comparison

DSY vs CTOR Comparison

Compare DSY & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSY
  • CTOR
  • Stock Information
  • Founded
  • DSY 2020
  • CTOR 2021
  • Country
  • DSY China
  • CTOR United States
  • Employees
  • DSY N/A
  • CTOR N/A
  • Industry
  • DSY
  • CTOR
  • Sector
  • DSY
  • CTOR
  • Exchange
  • DSY Nasdaq
  • CTOR NYSE
  • Market Cap
  • DSY 110.7M
  • CTOR 89.9M
  • IPO Year
  • DSY N/A
  • CTOR N/A
  • Fundamental
  • Price
  • DSY $2.17
  • CTOR $1.17
  • Analyst Decision
  • DSY
  • CTOR Strong Buy
  • Analyst Count
  • DSY 0
  • CTOR 2
  • Target Price
  • DSY N/A
  • CTOR $4.50
  • AVG Volume (30 Days)
  • DSY 106.0K
  • CTOR 60.9K
  • Earning Date
  • DSY 02-10-2025
  • CTOR 02-14-2025
  • Dividend Yield
  • DSY N/A
  • CTOR N/A
  • EPS Growth
  • DSY 120.37
  • CTOR N/A
  • EPS
  • DSY 0.01
  • CTOR N/A
  • Revenue
  • DSY $7,323,356.00
  • CTOR N/A
  • Revenue This Year
  • DSY N/A
  • CTOR N/A
  • Revenue Next Year
  • DSY N/A
  • CTOR N/A
  • P/E Ratio
  • DSY $166.38
  • CTOR N/A
  • Revenue Growth
  • DSY 16.37
  • CTOR N/A
  • 52 Week Low
  • DSY $0.75
  • CTOR $0.85
  • 52 Week High
  • DSY $13.47
  • CTOR $49.00
  • Technical
  • Relative Strength Index (RSI)
  • DSY 48.11
  • CTOR N/A
  • Support Level
  • DSY $1.79
  • CTOR N/A
  • Resistance Level
  • DSY $2.20
  • CTOR N/A
  • Average True Range (ATR)
  • DSY 0.38
  • CTOR 0.00
  • MACD
  • DSY 0.08
  • CTOR 0.00
  • Stochastic Oscillator
  • DSY 67.33
  • CTOR 0.00

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: